Duke Center for Precision Health Awards Pilot Funding to Advance Genomic Science
The Duke Center for Precision Health and Precision Genomics Collaboratory have awarded five pilot grants to advance genomic science at Duke by leveraging and enhancing the OneDukeGen study infrastructure. This opportunity was open to all Duke University School of Medicine faculty.
Engineering Health: A Duke Patient’s Impact on Genomics and the Future of Medicine
With a career that started at NASA and ended with engineering software for genomics research, Duke patient Sharon is not shy about her passion for science and the value of scientific research. It should come as no surprise then that when, during an appointment at the Duke Cardiac Catheterization Lab, she was asked to join the OneDukeGen study, she was all in.
Shaping the Future of Anesthesiology: Faculty Spotlight
Driven by a deep desire to heal, Mihai V. Podgoreanu, MD, searches for solutions as he seeks to transform perioperative medicine and critical care into a system that is not just reactive, but predictive, preventive, and personalized.
Lori Orlando Part of New NIH-funded Genomics Initiative Award
Duke University, in collaboration with the Veterans Health Administration (VA), has received one of six awards from a new $27 million initiative from the National Institutes of Health to establish a genomics-enabled Learning Health System (G-LHS) network
Links Between Health and Place in Durham
A first-of-its-kind study documents Durham neighborhoods with higher levels of structural racism also have higher rates of chronic disease. Duke researchers are expanding their work to help others conduct similar studies in their own cities, and to use that data to inform policy efforts to intervene where it’s needed most.
Center for Precision Health Leader Pens Editorial for JAMA Cardiology
In an editorial published in JAMA Cardiology, CPH faculty leader Senthil Selvaraj, MD, and others compare two approaches to improve detection of an underdiagnosed, undertreated systemic disease called transthyretin amyloidosis.
Improving the Odds: Using pharmacogenetic testing for treating depression
More than one in five people in the United States live with a mental illness, according to the National Institutes of Health. With several available drugs on the market for some of these conditions, like depression, it can be challenging to know what prescription will work best for individual patients. Oftentimes, though, these drugs take several weeks to feel the full effect, leaving patients in a state of limbo as they wait to see if their medication will work and provide them with relief or if they will need to try something else.
COVID Vaccination Not Associated with Kidney Disease in Black Adults at High Risk
Using data from community studies based at Duke Kannapolis, researchers found that COVID vaccination was not associated with new onset of APOL1-related kidney disease in African American adults who were at high risk for the condition.
Publications Detail Research from Project Baseline Health Study
Two journals have published findings from the Project Baseline Health Study, a community-based research initiative that collected, organized, and analyzed broad health data from thousands of participants over more than four years.
Inside Look: Women’s Health Health Lab 2024
This year’s event, in partnership with Northwell’s Katz Institute for Women’s Health, featured an array of exciting voices helping to change the landscape of women’s health.